Marc D. Zack
Pfizer Global Research and Development
Chesterfield
MO 63017
USA
Name/email consistency: high
- Reduced incidence and severity of experimental autoimmune arthritis in mice expressing catalytically inactive A disintegrin and metalloproteinase 8 (ADAM8). Zack, M.D., Melton, M.A., Stock, J.L., Storer, C.E., Barve, R.A., Minnerly, J.C., Weiss, D.J., Stejskal, J.A., Tortorella, M.D., Turk, J.R., Shevlin, K.M., Malfait, A.M. Clin. Exp. Immunol. (2009)
- ADAM-8 isolated from human osteoarthritic chondrocytes cleaves fibronectin at Ala(271). Zack, M.D., Malfait, A.M., Skepner, A.P., Yates, M.P., Griggs, D.W., Hall, T., Hills, R.L., Alston, J.T., Nemirovskiy, O.V., Radabaugh, M.R., Leone, J.W., Arner, E.C., Tortorella, M.D. Arthritis Rheum. (2009)
- Identification of fibronectin neoepitopes present in human osteoarthritic cartilage. Zack, M.D., Arner, E.C., Anglin, C.P., Alston, J.T., Malfait, A.M., Tortorella, M.D. Arthritis Rheum. (2006)